CVS Company Profile and Key Details

CVS has shown mixed momentum, losing -0.34% over the past week and -2.94% over the past quarter, though year-to-date performance is up 0.92%. Short-term trend indicators are mixed aligned (SMA20 1.88%, SMA50 -0.41%, SMA200 6.93%). The stock’s 14-day RSI is 52.0 (neutral), while the ATR of 2.45 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -8.39% below its high and over 33.69% above its low. Average 10-day trading volume of 6.94 million shares is below the 3-month average of 8.22 million, indicating normal recent market interest.

CVS Health Corp. has 1.27 billion shares outstanding. The public float is 1.27 billion shares, elevated short interest at 1.50% of float. This equals 18.80 million shares. The short ratio is 2.41 days. Institutional investors hold 90.4% of the float. Insiders own 0.06%. Moriarty Thomas M holds 608.13 thousand shares, MERLO LARRY J has 524.03 thousand shares and Lynch Karen S has 431.39 thousand shares. Over the past six months, insider transactions show net selling. They sold 448.50 thousand shares across 4 transactions.

CVS Health Corp. generated EPS of $1.38 over the past year. Five-year average earnings growth is -23.94%. Wall Street analysts project EPS growth of 11.83% annually over the next five years. The latest quarter delivered EPS of $2.57. The next quarter is forecast at $2.23. Next year's EPS is expected at -$0.80. Analyst sentiment is bullish. Analyst rating data shows there are 32 Strong Buy ratings, 14 Buy ratings, 4 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $115.00 to $67.00. The high target offers 9.82% upside. The low target suggests -36.02% downside. The mean target is $96.10. This offers -8.23% upside. CVS Health Corp. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended May 06, 2026, missed forecasts by 17.89%. The prior quarter beat by 9.0%. Over the last six quarters, Apple has recorded several small beats. These include 30.2% in February 12, 2025.

CVS Health Corp. last paid a dividend of 2.66 per share, this equals a trailing yield of roughly 4.26%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $266.10. This means the shares are trading below this model’s fair value.

CVS Health Corp. (NYSE:CVS) closed at $104.72 USD, losing -$0.09 (-0.09%) from the previous close of $104.81. The stock is currently within 5% of its 52-week high $58.50 and $106.15. With a market capitalization of about $133.62 billion, CVS Health Corp. is classified as a large-cap and shows lower-than-market volatility (beta ~0.60). Key stats such as the average daily volume over the past year has been around 8.34 million shares, volume is running light vs its 52-week average. Headquartered in Woonsocket, RI, CVS Health Corp. operates in the Healthcare sector and the Medical - Healthcare Plans industry. Led by CEO J. David Joyner, the company employs approximately 300,000 people and listed since February 21, 1973. CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services.

CVS Health Corp. (NYSE:CVS) shares are flat 0.92% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows CVS Health Corp. trading at a premium to the broader market with a P/E of 45.33. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $88.83, suggesting -15.17% downside. Our AI forecast model points to short-term strength (4.66% over two weeks), a medium-term rise (1.84% over three months), and a longer-term gain (2.61% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that CVS Health Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 4.66%, with price expected at $109.60 by July 16, 2026, within a range of $106.87 to $112.22 3-Month Outlook: Projected rise of 1.84%, reaching $106.65 by September 30, 2026, with a range of $92.92 to $117.20. 1-Year Outlook: Projected gain of 2.61%, with price at $107.45 by July 02, 2027, within a range of $103.63 to $110.85.

CVS Health Corp. trades at a P/E ratio of 45.33, slightly above the S&P 500 average, with a price-to-sales ratio of 0.33 and a price-to-book ratio of 1.72 suggesting the stock is closer to book value. The P/FCF stands at 18.07, also above market averages.